TY - JOUR
T1 - Peripheral phenotype and gene expression profiles of combined liver-kidney transplant patients
AU - Dumontet, Erwan
AU - Danger, Richard
AU - Vagefi, Parsia A.
AU - Londoño, Maria Carlota
AU - Pallier, Annaïck
AU - Lozano, Juan José
AU - Giral, Magali
AU - Degauque, Nicolas
AU - Soulillou, Jean Paul
AU - Martínez-Llordella, Marc
AU - Lee, Herman
AU - Latournerie, Marianne
AU - Boudjema, Karim
AU - Dulong, Joelle
AU - Tarte, Karin
AU - Sanchez-Fueyo, Alberto
AU - Feng, Sandy
AU - Brouard, Sophie
AU - Conchon, Sophie
PY - 2016/3
Y1 - 2016/3
N2 - Background and AimsThe beneficial effect of one graft on another has been reported in combined transplantation but the associated mechanisms and biological influence of each graft have not yet been established.MethodsIn multiple analyses, we explored the PBMC phenotype and signature of 45 immune-related messenger RNAs and 754 microRNAs from a total of 235 patients, including combined liver–kidney transplant recipients (CLK), patients with a liver (L-STA) or kidney (K-STA) graft only under classical immunosuppression and patients with tolerated liver (L-TOL) or kidney grafts (K-TOL).ResultsCLK show an intermediary phenotype with a higher percentage of peripheral CD19+CD24+CD38Low memory B cells and Helios+ Treg cells, two features associated with tolerance profiles, compared to L-STA and K-STA (P < 0.05, P < 0.01). Very few miRNA were significantly differentially expressed in CLK vs. K-STA and even fewer when compared to L-STA (35 and 8, P < 0.05). Finally, CLK are predicted to share common miRNA targets with K-TOL and even more with L-TOL (344 and 411, P = 0.005). Altogether CLK display an intermediary phenotype and gene profile, which is closer to that of liver transplant patients, with possible similarities with the profiles of tolerant patients.ConclusionThese data suggest that CLK patients show the immunological influence of both allografts with liver having a greater influence.
AB - Background and AimsThe beneficial effect of one graft on another has been reported in combined transplantation but the associated mechanisms and biological influence of each graft have not yet been established.MethodsIn multiple analyses, we explored the PBMC phenotype and signature of 45 immune-related messenger RNAs and 754 microRNAs from a total of 235 patients, including combined liver–kidney transplant recipients (CLK), patients with a liver (L-STA) or kidney (K-STA) graft only under classical immunosuppression and patients with tolerated liver (L-TOL) or kidney grafts (K-TOL).ResultsCLK show an intermediary phenotype with a higher percentage of peripheral CD19+CD24+CD38Low memory B cells and Helios+ Treg cells, two features associated with tolerance profiles, compared to L-STA and K-STA (P < 0.05, P < 0.01). Very few miRNA were significantly differentially expressed in CLK vs. K-STA and even fewer when compared to L-STA (35 and 8, P < 0.05). Finally, CLK are predicted to share common miRNA targets with K-TOL and even more with L-TOL (344 and 411, P = 0.005). Altogether CLK display an intermediary phenotype and gene profile, which is closer to that of liver transplant patients, with possible similarities with the profiles of tolerant patients.ConclusionThese data suggest that CLK patients show the immunological influence of both allografts with liver having a greater influence.
KW - Combined transplantation
KW - Gene expression
KW - Human
KW - Kidney transplantation
KW - Liver transplantation
KW - MicroRNA
KW - Phenotype
UR - http://www.scopus.com/inward/record.url?scp=84938802063&partnerID=8YFLogxK
U2 - 10.1111/liv.12917
DO - 10.1111/liv.12917
M3 - Article
SN - 1478-3223
VL - 36
SP - 401
EP - 409
JO - LIVER INTERNATIONAL
JF - LIVER INTERNATIONAL
IS - 3
ER -